News

Podcast

The first episode in our special three part mini-series.

06.04.2021

Published by bit.bio

The first episode in our special three part mini-series.

Published by bit.bio

Read now

Article

Q&A with Dr Mark Kotter: Transforming drug discovery & medical research

IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.

05.04.2021

Published by bit.bio

Read now

News

CEO Mark Kotter speaks at TEDxCambridgeUniversity

bit.bio CEO spoke about reprogramming human cells at the TEDxCambridgeUniversity ‘Untangling networks’ event.

26.03.2021

Published by bit.bio

Read now

News

Cultivated meat and cell therapies opti-ox™ technology underpins both

Today Meatable announced their Series A fundraise of $47 million. Read about the connection to bit.bio.

23.03.2021

Published by bit.bio

Read now

Press Release

Leading clinical immunotherapies developer Ramy Ibrahim joins bit.bio as Chief Medical Officer

Press release announcing appointment of Dr Ramy Ibrahim, MD, as Chief Medical Officer.

11.02.2021

Published by bit.bio

Read now

Press Release

Bit Bio secures $41.5 M of funding from top life sciences investors

bit.bio closes series A $41.5 million funding.

13.06.2020

Published by bit.bio

Read now

Related pages